Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
2017
Headcount
3
HQ
Binyamina-Giv'at Ada, Israel
Sector
Health Tech & Life Sciences
About
Lempo Therapeutics is an Israel-based, pre-clinical gene editing company utilizing CRISPR-Cas9 to edit stem cells ex vivo to inactivate disease-causing myeloperoxidase (MPO) proteins. Their lead candidate, MPO-001, is a treatment for modifying the myeloperoxidase protein in neutrophils by removing the MPO gene in CD34+ hematopoietic stem cells, primarily for pulmonary arterial hypertension (PAH). They are also exploring applications for inflammatory and autoimmune diseases, including Alzheimer's disease.
Headcount over time
From 1 (2019-11) to 3 (2022-08) · +2 (+200%) · 3 points · source: Finder history + radar grounding
Q&A
- What is Lempo Therapeutics' primary focus?
- Lempo Therapeutics is a preclinical biotech company focused on using gene editing to modify the immune system for attenuating severe chronic diseases. Their initial focus is on treating pulmonary arterial hypertension (PAH).
- When was Lempo Therapeutics founded?
- Lempo Therapeutics was founded in December 2017.
- Where is Lempo Therapeutics headquartered?
- Lempo Therapeutics is headquartered in Binyamina-Giv'at Ada, Israel.
- What is the current employee count for Lempo Therapeutics?
- Lempo Therapeutics has 1-10 employees.
- Who are the co-founders of Lempo Therapeutics?
- The co-founders of Lempo Therapeutics are Oren Glanz, who serves as CEO, and Prof. Ben-Zion Garty, who leads Clinical Research.
- What is Lempo Therapeutics' current funding stage?
- Lempo Therapeutics is currently in the Pre-Funding stage.
- Does Lempo Therapeutics hold any patents?
- Yes, Lempo Therapeutics holds one patent.
- What diseases has Lempo Therapeutics' concept shown effectiveness in animal models for?
- Lempo Therapeutics' concept has been proven effective in animal models for the treatment of Alzheimer's disease, multiple sclerosis, and cardiovascular diseases, among others.
Team · 2
Ben Zion Garty
Founder · Co-Founder
Oren Glanz
Founder · CEO and Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
treatmentscardiovascularmultiple-sclerosisalzheimers-diseasechronic-diseasehospitalsbiotechnologypharmaceuticalsgene-editingimmunologystem-cellsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | lempo-tx.com/ |
|---|---|
| linkedin.com/company/14046032 | |
| YouTube | youtube.com/channel/UCnLzOr-ZPMaW8_33lxURndw |
Identifiers & details
| Former names | Lempo Research |
|---|---|
| Founded | 2017 |
| Employees (exact) | 3 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | lempo-tx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515757581 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-12-18 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | ששת הימים 86 בנימינה |
Recent registry events
| Date | Event |
|---|---|
| 2025-07-31 | דו~ח שנתי |